Nanalysis Scientific Corp. (TSXV:NSCI)
Canada · Delayed Price · Currency is CAD 0.1100
-0.0250 (-18.52%)
At close: Aug 26, 2026
Nanalysis Scientific Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 40.35 | 40.13 | 45.5 | 28.47 | 24.82 | 16.04 | |
Revenue Growth | -6.23% | -11.79% | 59.82% | 14.69% | 54.72% | 103.75% |
Cost of Revenue | 30.49 | 30.17 | 32.75 | 24.5 | 14.35 | 5.8 |
Gross Profit | 9.86 | 9.96 | 12.75 | 3.97 | 10.47 | 10.24 |
Selling, General & Admin | 8.01 | 9.71 | 10.27 | 11.37 | 12.94 | 7.69 |
Research & Development | 0.57 | 0.43 | 0.54 | 0.68 | 1.47 | 0.64 |
Operating Expenses | 11.89 | 13.73 | 16.19 | 17.46 | 20.52 | 11.43 |
Operating Income | -2.03 | -3.77 | -3.45 | -13.49 | -10.06 | -1.19 |
Interest Expense | -1.4 | -1.37 | -1.35 | -0.28 | -0.08 | - |
Interest & Investment Income | - | - | - | - | - | 0 |
Earnings From Equity Investments | - | - | -1.09 | -0.53 | - | - |
Currency Exchange Gain (Loss) | 0.04 | 0.04 | -0.03 | -0.17 | -0.16 | -0.04 |
Other Non Operating Income (Expenses) | -0.02 | - | -0.5 | - | - | - |
EBT Excluding Unusual Items | -3.4 | -5.1 | -6.4 | -14.46 | -10.3 | -1.23 |
Merger & Restructuring Charges | -0.84 | -0.7 | -0.29 | -0.44 | -0.1 | -0.19 |
Gain (Loss) on Sale of Investments | - | - | -4.64 | - | - | - |
Gain (Loss) on Sale of Assets | 0.04 | 0.04 | -0.09 | -2.86 | - | - |
Asset Writedown | - | - | -1.46 | - | - | - |
Other Unusual Items | 0.05 | 0.12 | -0.75 | 0.97 | - | -0.35 |
Pretax Income | -4.16 | -5.64 | -13.64 | -16.8 | -10.4 | -1.77 |
Income Tax Expense | 0.02 | 0.02 | -0.02 | -0.01 | -0.48 | - |
Earnings From Continuing Operations | -4.18 | -5.66 | -13.61 | -16.78 | -9.92 | -1.77 |
Minority Interest in Earnings | - | - | - | 0.59 | 0.81 | - |
Net Income | -4.18 | -5.66 | -13.61 | -16.2 | -9.1 | -1.77 |
Net Income to Common | -4.18 | -5.66 | -13.61 | -16.2 | -9.1 | -1.77 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 127 | 115 | 111 | 99 | 92 | 70 |
Shares Outstanding (Diluted) | 127 | 115 | 111 | 99 | 92 | 70 |
Shares Change | 12.02% | 3.68% | 11.56% | 7.25% | 31.35% | 7.77% |
EPS (Basic) | -0.03 | -0.05 | -0.12 | -0.16 | -0.10 | -0.03 |
EPS (Diluted) | -0.03 | -0.05 | -0.12 | -0.16 | -0.10 | -0.03 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 2.74 | 3.17 | 3.21 | -11.92 | -10.67 | -1.79 |
Free Cash Flow Per Share | 0.02 | 0.03 | 0.03 | -0.12 | -0.12 | -0.03 |
Gross Margin | 24.44% | 24.83% | 28.02% | 13.95% | 42.18% | 63.83% |
Operating Margin | -5.02% | -9.38% | -7.57% | -47.38% | -40.51% | -7.42% |
Profit Margin | -10.35% | -14.10% | -29.92% | -56.90% | -36.67% | -11.04% |
Free Cash Flow Margin | 6.79% | 7.90% | 7.05% | -41.88% | -43.00% | -11.18% |
EBITDA | -3.05 | -3.11 | -2.41 | -12.33 | -8.81 | -0.57 |
EBITDA Margin | -7.55% | -7.76% | -5.30% | -43.32% | -35.47% | -3.58% |
D&A For EBITDA | -1.02 | 0.65 | 1.03 | 1.16 | 1.25 | 0.62 |
EBIT | -2.03 | -3.77 | -3.45 | -13.49 | -10.06 | -1.19 |
EBIT Margin | -5.02% | -9.38% | -7.57% | -47.38% | -40.51% | -7.42% |
Revenue as Reported | 40.35 | 40.13 | 45.5 | 28.47 | 24.82 | 16.04 |